Which hedge funds own CRMD? CORMEDIX INC, Q2 2026 13F holders
23 tracked hedge funds disclosed a position in CRMD (CORMEDIX INC) in their Q2 2026 13F filings, worth $80.9m in total. The largest holder by portfolio weight is Deep Track Capital, LP at 0.7% of its book. 10 opened a new position this quarter: Armistice Capital, LLC, Fox Run Management, L.L.C., ExodusPoint Capital Management, LP, Fulcrum Asset Management LLP. 3 exited: Sculptor Capital LP, Campbell & CO Investment Adviser LLC, Verition Fund Management LLC.
- 23
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 10
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 3
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $8.8m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $2.5m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $80.9m
- Combined value Sum of the holders' reported positions in the security.
- 1.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Sculptor Capital LP | 0.03% | $2.3m |
| Campbell & CO Investment Adviser LLC | 0.0% | $77.4k |
| Verition Fund Management LLC | 0.0% | $151k |
Ownership over time
Who discovered CRMD first? Beta
The run: Q1 2018 → Q1 2019, +950%
| Sabby Management, LLC | Q3 2019 | – | +0.2 pts |
| Deep Track Capital, LP | Q4 2025 | – | −0.4 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.